Nef-mediated down-regulation of CD4 and HLA class I in HIV-1 subtype C infection: Association with disease progression and influence of immune pressure
- Jaclyn K Mann ,
- Denis Chopera ,
- Saleha Omarjee ,
- Xiaomei T Kuang ,
- Anh Q Le ,
- Gursev Anmole ,
- Ryan Danroth ,
- Philip Mwimanzi ,
- Tarylee Reddy ,
- Jonathan M. Carlson ,
- Mopo Radebe ,
- Philip JR Goulder ,
- Bruce D Walker ,
- Salim Abdool Karim ,
- Vladimir Novitsky ,
- Carolyn Williamson ,
- Mark A Brockman ,
- Zabrina L Brumme ,
- Thumbi Ndung'u
Virology | , pp. 214-225
Nef plays a major role in HIV-1 pathogenicity. We studied HIV-1 subtype C infected individuals in acute/early (n=120) or chronic (n=207) infection to investigate the relationship between Nef-mediated CD4/HLA-I down-regulation activities and disease progression, and the influence of immune-driven sequence variation on these Nef functions. A single Nef sequence per individual was cloned into an expression plasmid, followed by transfection of a T cell line and measurement of CD4 and HLA-I expression. In early infection, a trend of higher CD4 down-regulation ability correlating with higher viral load set point was observed (r=0.19, p=0.05), and higher HLA-I down-regulation activity was significantly associated with faster rate of CD4 decline (p=0.02). HLA-I down-regulation function correlated inversely with the number HLA-associated polymorphisms previously associated with reversion in the absence of the selecting HLA allele (r=−0.21, p=0.0002). These data support consideration of certain Nef regions in HIV-1 vaccine strategies designed to attenuate the infection course.